Tumor calcification as a prognostic factor in cetuximab plus chemotherapy-treated patients with metastatic colorectal cancerYuwen Zhou, Meng Qiu, Ye Chen et al.|Anti-Cancer Drugs|2018Cited by 44
A phase II study of tislelizumab (TIS) and chemotherapy as neoadjuvant therapy for potentially resectable stage IIIA/IIIB non-small cell lung cancer (NSCLC).Ting Wang, Qing Zhou, Lu Li et al.|Journal of Clinical Oncology|2024Cited by 3